Table 18. Systematic Review Examining Predictors of Spinal Stenosis

Author Year

Country
Research Design
AMSTAR Score
Sample Size

Methods Outcomes

Wilson et al. (2013b)

Canada

Systematic Review

AMSTAR=7

N=5 studies

Objective: To assess the frequency, timing, and predictors of symptom development in individuals with radiographical evidence of spinal cord compression (SCC), spinal canal stenosis (SCS), and/or ossification of posterior longitudinal ligament (OPLL) but no symptoms of myelopathy.

Methods: Comprehensive literature search of English longitudinal cohort studies of participants aged >18 yr with imaging evidence of SCC, SCN, or OPLL, without symptoms of myelopathy and history of tumor, infection, arthritis, or previous SCI. Data analysis was performed by calculating relative risks (RR) and 95% confidence intervals (95%CI).

Databases: MEDLINE, Cochrane, Google Scholar.

Evidence: Studies were assessed for quality using AHRQ guidelines (I, II, or III). Levels of evidence were assigned GRADE criteria (insufficient, low, moderate, or high). Clinical recommendations were made using a modified Delphi approach (weak or strong). Statistical significance was defined as p<0.05.

1.     Quality of studies was II (n=1) and III (n=4).

2.     Overall strength of evidence was moderate.

3.     Overall strength of recommendations was strong.

4.     Only three studies (n=355) of the total five (n=832) were included in meta-analysis.

5.     In SCC or SCS (n=199), myelopathy development within 44 mo (24-144 mo) was 22.6%.

6.     In SCC or SCS, significant predictors of myelopathy development were presence of symptomatic radiculopathy (RR=3.0, 95%CI=2.0-4.4, p=0.007), prolonged somatosensory-evoked potentials (RR=2.9, 95%CI=1.7-5.1, p=0.007), prolonged motor-evoked potentials (RR=3.2, 95%CI=1.9-5.6, p=0.033), and lack of cervical cord MRI hyperintensity (RR=1.7, 95%CI=1.0-2.7, p=0.0036).

7.     In OPLL (n=606), myelopathy development within 60-360 mo ranged from 17.0% to 61.5%.

8.     In a subset of OPLL (n=156), predictors of myelopathy development were lateral deviation (RR=2.1, 95%CI=1.4-3.1), increased cervical range of motion (p=0.03), and canal stenosis >60%.

9.     The authors made a strong recommendation based on moderate evidence: individuals with SCC/SCS secondary to spondylosis, without evidence of myelopathy, and with clinical or electrophysiological evidence of cervical radicular dysfunction or central conduction deficits may be at higher risk for development myelopathy and should be considered for surgical intervention.

top